Literature DB >> 29852187

Targeting Keap-1/Nrf-2 pathway and cytoglobin as a potential protective mechanism of diosmin and pentoxifylline against cholestatic liver cirrhosis.

Fares E M Ali1, Adel G Bakr2, Amira M Abo-Youssef3, Amany A Azouz3, Ramadan A M Hemeida2.   

Abstract

AIM: The effects of diosmin (DS), pentoxifylline (PTX) and their combination on inflammatory response, oxidant/antioxidant balance, cytoglobin and cirrhotic reaction during bile duct ligation (BDL) were investigated and explored. MAIN
METHODS: Fifty adult male Wistar albino rats were randomly allocated to five groups as following, sham: received vehicle only, BDL: subjected to common BDL without treatment, BDL plus DS: received 100 mg/kg/day orally, BDL plus PTX: received 50 mg/kg/day orally, BDL plus DS plus PTX: received DS and PTX in the same manner. The test period lasted 28 days, liver tissues and blood samples were collected to investigate biochemical markers (liver function biomarkers, oxidative stress markers, and antifibrotic markers), mRNA expression of Nrf-2, Keap-1, NF-κB-p65 and p38-MAPK by real-time PCR, protein expression of cytoglobin and NF-κB-p65 by western blot and iNOS and eNOS by immunohistochemistry. Histopathological study was performed to confirm our results. KEY
FINDINGS: Chronic BDL induced a significant alteration in liver functions, oxidative stress and fibrotic markers. Furthermore, unfavorable effects on gene and protein expression were observed after BDL. Histopathological findings of this group showed parallel effects. DS, PTX and their combination treatment significantly ameliorated the disturbance that occurred due to BDL. Similar findings were observed in liver histopathology. SIGNIFICANCE: DS and PTX could mitigate liver cirrhosis through modulation of Keap-1/Nrf-2/GSH and NF-κB-p65/p38-MAPK signaling pathways. In addition, we demonstrated that the hepatoprotective effect of DS and PTX is mediated by up-regulation of cytoglobin with inhibition of fibrotic reaction.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bile duct ligation; Cytoglobin; Diosmin; Keap-1/Nrf-2; Pentoxifylline

Mesh:

Substances:

Year:  2018        PMID: 29852187     DOI: 10.1016/j.lfs.2018.05.048

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Candesartan Protects Against Cadmium-Induced Hepatorenal Syndrome by Affecting Nrf2, NF-κB, Bax/Bcl-2/Cyt-C, and Ang II/Ang 1-7 Signals.

Authors:  Esam O Kamel; Wail M Gad-Elrab; Mohammed A Ahmed; Zuhair M Mohammedsaleh; Emad H M Hassanein; Fares E M Ali
Journal:  Biol Trace Elem Res       Date:  2022-05-19       Impact factor: 3.738

Review 2.  Biliatresone: progress in biliary atresia study.

Authors:  Jia-Jie Zhu; Yi-Fan Yang; Rui Dong; Shan Zheng
Journal:  World J Pediatr       Date:  2022-09-27       Impact factor: 9.186

Review 3.  Antiretroviral Therapy-Induced Dysregulation of Gene Expression and Lipid Metabolism in HIV+ Patients: Beneficial Role of Antioxidant Phytochemicals.

Authors:  Angélica Saraí Jiménez-Osorio; Sinaí Jaen-Vega; Eduardo Fernández-Martínez; María Araceli Ortíz-Rodríguez; María Fernanda Martínez-Salazar; Reyna Cristina Jiménez-Sánchez; Olga Rocío Flores-Chávez; Esther Ramírez-Moreno; José Arias-Rico; Felipe Arteaga-García; Diego Estrada-Luna
Journal:  Int J Mol Sci       Date:  2022-05-17       Impact factor: 6.208

4.  Cytoglobin protects cancer cells from apoptosis by regulation of mitochondrial cardiolipin.

Authors:  Lorna S Thorne; Garret Rochford; Timothy D Williams; Andrew D Southam; Giovanny Rodriguez-Blanco; Warwick B Dunn; Nikolas J Hodges
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

Review 5.  New Drugs for Hepatic Fibrosis.

Authors:  Liang Shan; Fengling Wang; Dandan Zhai; Xiangyun Meng; Jianjun Liu; Xiongwen Lv
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

Review 6.  Management of COVID-19-induced cytokine storm by Keap1-Nrf2 system: a review.

Authors:  Ekta Singh; Gurubasavaraja Swamy Purawarga Matada; Nahid Abbas; Prasad Sanjay Dhiwar; Abhishek Ghara; Arka Das
Journal:  Inflammopharmacology       Date:  2021-08-09       Impact factor: 4.473

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.